NLS Cellink

BICO has acquired all the shares in San Diego-based Allegro 3D for an up-front enterprise value of USD 6 million. Additionally, the shareholders can receive USD 5 million in an earnout payment contingent on Allegro 3D’s financial performance in the coming two years. The entire purchase price will be paid in cash. Allegro 3D’s patented […]

BICO has acquired all outstanding shares in Advanced BioMatrix, an American company focusing on 3D research applications. The Advanced BioMatrix portfolio includes collagen bioinks, high purity extracellular matrix proteins, chemically modified proteins and polysaccharides, and other reagents and cell assays, sold to research institutions, and pharmaceutical and biotech companies. The company has a particularly strong […]

The company has entered into an agreement with the shareholders of Discover Echo to acquire all outstanding shares to a purchase price of USD 110 million. Approximately eleven percent of the purchase price will be paid in newly issued shares of series B in CELLINK and the remaining part will be paid cash. Discover Echo […]

Cellink has entered into an agreement with the shareholders of Ginolis to acquire all shares for a purchase price on cash- and debt-free basis of EUR 70 million. Ginolis is a Finnish company focusing on diagnostics automation and advanced robotics solutions for medical and diagnostic industries, according to Cellink’s press release. “With this strategic acquisition […]

The bioink company has entered an agreement with the owners of Cytena to acquire all its shares for a purchase price of 30.25M euros. Through cytena’s complementary technology offering, Cellink sees great synergies that will support future growth. About Cytena Cytena is a life science company focusing on single-cell technologies. It was founded in 2014 […]